Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,206 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Subgroup analysis of clinical and MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study.
Cree BAC, Bowen JD, Hartung HP, Vermersch P, Hughes B, Damian D, Hyvert Y, Dangond F, Galazka A, Grosso M, Jones DL, Leist TP. Cree BAC, et al. Among authors: hartung hp. Mult Scler Relat Disord. 2020 Dec 24;49:102695. doi: 10.1016/j.msard.2020.102695. Online ahead of print. Mult Scler Relat Disord. 2020. PMID: 33578191 Free article.
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Cree BA, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk D, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Williams IM, Drappa J, She D, Cimbora D, Rees W, Ratchford JN, Katz E. Cree BA, et al. Among authors: hartung hp. Mult Scler. 2021 Feb 4:1352458521988926. doi: 10.1177/1352458521988926. Online ahead of print. Mult Scler. 2021. PMID: 33538237
Effect of Ozanimod on Symbol Digit Modalities Test Performance in Relapsing MS.
DeLuca J, Schippling S, Montalban X, Kappos L, Cree BAC, Comi G, Arnold DL, Hartung HP, Sheffield JK, Liu H, Silva D, Cohen JA. DeLuca J, et al. Among authors: hartung hp. Mult Scler Relat Disord. 2021 Feb;48:102673. doi: 10.1016/j.msard.2020.102673. Epub 2020 Dec 10. Mult Scler Relat Disord. 2021. PMID: 33454584 Free article.
1,206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page